This program is studying a compound designed to block the function of neutrophil elastase. Neutrophil elastase is a type of protein associated with inflammation in the lungs. Blocking the function of neutrophil elastase may minimise tissue destruction and decrease inflammation within the CF airway.
Phase 1 studies to test the safety of this compound are underway in Europe.
This program is sponsored by Santhera.
Contact us about Lonodelestat (formerly POL6014) >